Global Mental Health Screening Market - 2025 -2033
Industry Outlook
The global mental health screening market reached US$ 0.90 billion in 2023, with a rise of US$ 1.00 billion in 2024, and is expected to reach US$ 2.78 billion by 2033, growing at a CAGR of 12.1% during the forecast period 2025-2033.
The mental health screening market is undergoing a transformation driven by rapid advancements in digital health technologies, including AI-powered diagnostic tools, mobile-based assessments, and wearable-integrated monitoring systems. These innovations enable real-time symptom tracking, early detection of mental health conditions, and personalized screening approaches. Integration of big data and genomics is enhancing the ability to identify at-risk populations and predict mental health trends.
Market Dynamics: Drivers & Restraints
Driver: Rising prevalence of mental disorders
The rising prevalence of mental disorders is expected to be a major driving force behind the growth of the mental health screening market. Conditions such as depression, anxiety, bipolar disorder, PTSD, and substance abuse have seen a significant increase globally, driven by factors like urbanization, social isolation, economic stress, and lifestyle changes.
For instance, according to the World Health Organization in 2023, Mental health has become a major public health concern globally, with over 1 billion people affected by mental, neurological, and substance use disorders. The burden is particularly significant in the Eastern Mediterranean Region, where an estimated 14.7% of the population is living with a mental health condition, marking the second-highest prevalence among all WHO regions. This surge in mental health issues has led to greater demand for early detection and intervention, pushing healthcare systems, employers, and digital health platforms to adopt more comprehensive screening tools. As awareness grows and stigma around mental illness gradually decreases, routine mental health screening is becoming an essential part of preventive care, further propelling market expansion.
Restraint: Lack of mental health professionals
The lack of mental health professionals poses a significant challenge to the growth of the mental health screening market. While demand for mental health screening is rising due to increased awareness and prevalence of disorders, many regions face severe shortages of trained psychiatrists, psychologists, and counselors. This gap limits the capacity for accurate diagnosis, follow-up care, and interpretation of screening results. Even with digital tools and AI-driven platforms, human oversight remains crucial in confirming diagnoses and initiating treatment plans.
Segment Analysis
The global mental health screening market is segmented based on disorder type, screening method, component, age group, end-user, and region.
Treatment Type:
The physiological disorders segment is estimated to have 44.4% of the mental health screening market share.
The physiological disorders segment is projected to hold a significant share of the mental health screening market, driven by the rising global prevalence of conditions such as bipolar disorder, eating disorders, substance abuse, depression, anxiety, and post-traumatic stress disorder (PTSD). These disorders represent some of the most commonly diagnosed mental health conditions worldwide, prompting increased demand for early detection and intervention.
For instance, according to the 2021 Global Burden of Disease study, there were approximately 444 million new cases of mental disorders worldwide, with an age-standardized incidence rate (ASIR) of 5,460 per 100,000 population, representing a 16% increase since 2019.
Growing public awareness, government support, and advancements in digital screening tools have further accelerated screening efforts. As mental health becomes a greater priority across healthcare systems, this segment is expected to remain a key area of focus in clinical practice and research.
Geographical Analysis
The North America mental health screening market was valued at 40.20% market share in 2024
North America is expected to dominate the mental health screening market due to several key factors. The region has a high prevalence of mental health disorders, coupled with increasing public awareness and reduced stigma around mental health care. Strong healthcare infrastructure, widespread adoption of advanced digital screening technologies, and significant government support through policies and funding further drive market growth.
Additionally, North America benefits from the active involvement of major technology companies and startups developing AI-powered and telehealth screening solutions, making mental health services more accessible. For instance, in June 2025, Wysa, a global leader in AI-driven mental health support, announced the U.S. launch of Wysa Gateway, an AI-powered chatbot aimed at improving how therapy providers and health plans connect patients to care. Wysa Gateway automates clinical screenings using advanced AI, offering a faster, more accurate, and personalized entry point into therapy services.
Growing employer initiatives promoting employee mental wellness and well-established reimbursement frameworks also contribute to the region’s leadership in the market.
Major Players
The major players in the mental health screening market include Modern Life, Inc., FuturesThrive, Aiberry, Ezovion, AdvancedMD, Inc., Networking Technology, Inc. dba RXNT, Amaha, Wellin5 Innovations Inc., among others.
Key Developments
The global mental health screening market reached US$ 0.90 billion in 2023, with a rise of US$ 1.00 billion in 2024, and is expected to reach US$ 2.78 billion by 2033, growing at a CAGR of 12.1% during the forecast period 2025-2033.
The mental health screening market is undergoing a transformation driven by rapid advancements in digital health technologies, including AI-powered diagnostic tools, mobile-based assessments, and wearable-integrated monitoring systems. These innovations enable real-time symptom tracking, early detection of mental health conditions, and personalized screening approaches. Integration of big data and genomics is enhancing the ability to identify at-risk populations and predict mental health trends.
Market Dynamics: Drivers & Restraints
Driver: Rising prevalence of mental disorders
The rising prevalence of mental disorders is expected to be a major driving force behind the growth of the mental health screening market. Conditions such as depression, anxiety, bipolar disorder, PTSD, and substance abuse have seen a significant increase globally, driven by factors like urbanization, social isolation, economic stress, and lifestyle changes.
For instance, according to the World Health Organization in 2023, Mental health has become a major public health concern globally, with over 1 billion people affected by mental, neurological, and substance use disorders. The burden is particularly significant in the Eastern Mediterranean Region, where an estimated 14.7% of the population is living with a mental health condition, marking the second-highest prevalence among all WHO regions. This surge in mental health issues has led to greater demand for early detection and intervention, pushing healthcare systems, employers, and digital health platforms to adopt more comprehensive screening tools. As awareness grows and stigma around mental illness gradually decreases, routine mental health screening is becoming an essential part of preventive care, further propelling market expansion.
Restraint: Lack of mental health professionals
The lack of mental health professionals poses a significant challenge to the growth of the mental health screening market. While demand for mental health screening is rising due to increased awareness and prevalence of disorders, many regions face severe shortages of trained psychiatrists, psychologists, and counselors. This gap limits the capacity for accurate diagnosis, follow-up care, and interpretation of screening results. Even with digital tools and AI-driven platforms, human oversight remains crucial in confirming diagnoses and initiating treatment plans.
Segment Analysis
The global mental health screening market is segmented based on disorder type, screening method, component, age group, end-user, and region.
Treatment Type:
The physiological disorders segment is estimated to have 44.4% of the mental health screening market share.
The physiological disorders segment is projected to hold a significant share of the mental health screening market, driven by the rising global prevalence of conditions such as bipolar disorder, eating disorders, substance abuse, depression, anxiety, and post-traumatic stress disorder (PTSD). These disorders represent some of the most commonly diagnosed mental health conditions worldwide, prompting increased demand for early detection and intervention.
For instance, according to the 2021 Global Burden of Disease study, there were approximately 444 million new cases of mental disorders worldwide, with an age-standardized incidence rate (ASIR) of 5,460 per 100,000 population, representing a 16% increase since 2019.
Growing public awareness, government support, and advancements in digital screening tools have further accelerated screening efforts. As mental health becomes a greater priority across healthcare systems, this segment is expected to remain a key area of focus in clinical practice and research.
Geographical Analysis
The North America mental health screening market was valued at 40.20% market share in 2024
North America is expected to dominate the mental health screening market due to several key factors. The region has a high prevalence of mental health disorders, coupled with increasing public awareness and reduced stigma around mental health care. Strong healthcare infrastructure, widespread adoption of advanced digital screening technologies, and significant government support through policies and funding further drive market growth.
Additionally, North America benefits from the active involvement of major technology companies and startups developing AI-powered and telehealth screening solutions, making mental health services more accessible. For instance, in June 2025, Wysa, a global leader in AI-driven mental health support, announced the U.S. launch of Wysa Gateway, an AI-powered chatbot aimed at improving how therapy providers and health plans connect patients to care. Wysa Gateway automates clinical screenings using advanced AI, offering a faster, more accurate, and personalized entry point into therapy services.
Growing employer initiatives promoting employee mental wellness and well-established reimbursement frameworks also contribute to the region’s leadership in the market.
Major Players
The major players in the mental health screening market include Modern Life, Inc., FuturesThrive, Aiberry, Ezovion, AdvancedMD, Inc., Networking Technology, Inc. dba RXNT, Amaha, Wellin5 Innovations Inc., among others.
Key Developments
- In July 2025, Google unveiled two new artificial intelligence initiatives aimed at helping mental health organizations scale evidence-based interventions and advance research into treatments for anxiety, depression, and psychosis.
- In May 2025, JD Health’s Mental Health Service Center introduced a range of AI-powered service initiatives at a conference in Beijing. The new offerings include an AI therapeutic companion called “Small Universe for Chatting and Healing,” designed to provide emotional support to users, along with multimodal diagnostic and digital management tools for healthcare professionals. This marks JD Health as the first AI-driven online mental health service platform in China.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Disorder Type
2.4. Snippet by Screening Method
2.5. Snippet by Component
2.6. Snippet by Age Group
2.7. Snippet by End-User
2.8. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Prevalence of Mental Disorders
3.1.1.2. Advances in Technology
3.1.2. Restraints
3.1.2.1. Lack of Mental Health Professionals
3.1.2.2. Data Privacy Concerns
3.1.3. Opportunity
3.1.3.1. AI-powered Personalized Screening
3.1.3.2. Integration with Primary Care
3.1.4. Impact Analysis
4. GLOBAL MENTAL HEALTH SCREENING MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL MENTAL HEALTH SCREENING MARKET: BY DISORDER TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
5.1.2. Market Attractiveness Index, By Disorder Type
5.2. Cognitive Disorders*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.2.3. Alzheimer’s Disease
5.2.4. Cognitive Impairment
5.2.5. Dementia
5.2.6. Others
5.3. Behavioral Disorders
5.3.1. Sleep Disorder
5.3.2. Social Withdrawal
5.3.3. Dissociative Disorder
5.3.4. Hyperactivity
5.3.5. Self-Harm
5.3.6. Aggression
5.3.7. Others
5.4. Physiological Disorders
5.4.1. Bipolar Disorder
5.4.2. Eating Disorder
5.4.3. Substance Abuse
5.4.4. Depression
5.4.5. Anxiety
5.4.6. Post-Traumatic Stress Disorder (PTSD)
5.4.7. Others
5.5. Psychotic Disorders
5.5.1. Dissociative Disorder
5.5.2. Obsessive Compulsive Disorder
5.5.3. Schizophrenia
5.5.4. Dissociative Disorder
5.5.5. Attention Deficit Hyperactivity Disorder (ADHD)
5.5.6. Others
6. GLOBAL MENTAL HEALTH SCREENING MARKET: BY SCREENING METHOD
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Screening Method
6.1.2. Market Attractiveness Index, By Screening Method
6.2. Self-Reported Questionnaires*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Clinical Interviews
6.4. Observation-Based Assessments
6.5. Biomarker Testing
6.6. Others
7. GLOBAL MENTAL HEALTH SCREENING MARKET: BY COMPONENT
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
7.1.2. Market Attractiveness Index, By Component
7.2. Hardware*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Software
7.3.1. AI-Based Screening Tools
7.3.2. Self-screening mHealth Apps
7.3.3. Remote Mental Health Platforms & Virtual Care Solutions
7.3.4. Telehealth
7.4. Services
8. GLOBAL MENTAL HEALTH SCREENING MARKET: BY AGE GROUP
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
8.1.2. Market Attractiveness Index, By Age Group
8.2. Children*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Adults (Age 19-64)
8.4. Seniors (Age 65 and above)
9. GLOBAL MENTAL HEALTH SCREENING MARKET: BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals and Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Educational Institutions
9.4. Workplaces
9.5. Homecare Settings
10. GLOBAL MENTAL HEALTH SCREENING MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Screening Method
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.8.1. U.S.
10.2.8.2. Canada
10.2.8.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Screening Method
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.8.1. Germany
10.3.8.2. U.K.
10.3.8.3. France
10.3.8.4. Spain
10.3.8.5. Italy
10.3.8.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Screening Method
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.8.1. Brazil
10.4.8.2. Argentina
10.4.8.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Screening Method
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.8.1. China
10.5.8.2. India
10.5.8.3. Japan
10.5.8.4. South Korea
10.5.8.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Screening Method
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
11.1. Competitive Overview and Key Market Players
11.1.1. Market Share Analysis and Positioning Matrix
11.1.2. Strategic Partnerships, Mergers & Acquisitions
11.1.3. Key Developments in Product Portfolios and Innovations
11.1.4. Company Benchmarking
12. COMPANY PROFILES
12.1. Modern Life, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio
12.1.2.1. Product Description
12.1.2.2. Product Key Performance Indicators (KPIs)
12.1.2.3. Historic and Forecasted Product Sales
12.1.2.4. Product Sales Volume
12.1.3. Financial Overview
12.1.3.1. Company Revenue
12.1.3.2. Geographical Revenue Shares
12.1.3.3. Revenue Forecasts
12.1.4. Key Developments
12.1.4.1. Mergers & Acquisitions
12.1.4.2. Key Product Development Activities
12.1.4.3. Regulatory Approvals, etc.
12.1.4.4. SWOT Analysis
12.2. FuturesThrive
12.3. Aiberry
12.4. Ezovion
12.5. AdvancedMD, Inc.
12.6. Networking Technology, Inc. dba RXNT
12.7. Amaha
12.8. Wellin5 Innovations Inc. (LIST NOT EXHAUSTIVE)
13. ASSUMPTIONS AND RESEARCH METHODOLOGY
13.1. Data Collection Methods
13.2. Data Triangulation
13.3. Forecasting Techniques
13.4. Data Verification and Validation
14. APPENDIX
14.1. About Us and Services
14.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Disorder Type
2.4. Snippet by Screening Method
2.5. Snippet by Component
2.6. Snippet by Age Group
2.7. Snippet by End-User
2.8. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Prevalence of Mental Disorders
3.1.1.2. Advances in Technology
3.1.2. Restraints
3.1.2.1. Lack of Mental Health Professionals
3.1.2.2. Data Privacy Concerns
3.1.3. Opportunity
3.1.3.1. AI-powered Personalized Screening
3.1.3.2. Integration with Primary Care
3.1.4. Impact Analysis
4. GLOBAL MENTAL HEALTH SCREENING MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL MENTAL HEALTH SCREENING MARKET: BY DISORDER TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
5.1.2. Market Attractiveness Index, By Disorder Type
5.2. Cognitive Disorders*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.2.3. Alzheimer’s Disease
5.2.4. Cognitive Impairment
5.2.5. Dementia
5.2.6. Others
5.3. Behavioral Disorders
5.3.1. Sleep Disorder
5.3.2. Social Withdrawal
5.3.3. Dissociative Disorder
5.3.4. Hyperactivity
5.3.5. Self-Harm
5.3.6. Aggression
5.3.7. Others
5.4. Physiological Disorders
5.4.1. Bipolar Disorder
5.4.2. Eating Disorder
5.4.3. Substance Abuse
5.4.4. Depression
5.4.5. Anxiety
5.4.6. Post-Traumatic Stress Disorder (PTSD)
5.4.7. Others
5.5. Psychotic Disorders
5.5.1. Dissociative Disorder
5.5.2. Obsessive Compulsive Disorder
5.5.3. Schizophrenia
5.5.4. Dissociative Disorder
5.5.5. Attention Deficit Hyperactivity Disorder (ADHD)
5.5.6. Others
6. GLOBAL MENTAL HEALTH SCREENING MARKET: BY SCREENING METHOD
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Screening Method
6.1.2. Market Attractiveness Index, By Screening Method
6.2. Self-Reported Questionnaires*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Clinical Interviews
6.4. Observation-Based Assessments
6.5. Biomarker Testing
6.6. Others
7. GLOBAL MENTAL HEALTH SCREENING MARKET: BY COMPONENT
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
7.1.2. Market Attractiveness Index, By Component
7.2. Hardware*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Software
7.3.1. AI-Based Screening Tools
7.3.2. Self-screening mHealth Apps
7.3.3. Remote Mental Health Platforms & Virtual Care Solutions
7.3.4. Telehealth
7.4. Services
8. GLOBAL MENTAL HEALTH SCREENING MARKET: BY AGE GROUP
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
8.1.2. Market Attractiveness Index, By Age Group
8.2. Children*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Adults (Age 19-64)
8.4. Seniors (Age 65 and above)
9. GLOBAL MENTAL HEALTH SCREENING MARKET: BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals and Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Educational Institutions
9.4. Workplaces
9.5. Homecare Settings
10. GLOBAL MENTAL HEALTH SCREENING MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Screening Method
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.8.1. U.S.
10.2.8.2. Canada
10.2.8.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Screening Method
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.8.1. Germany
10.3.8.2. U.K.
10.3.8.3. France
10.3.8.4. Spain
10.3.8.5. Italy
10.3.8.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Screening Method
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.8.1. Brazil
10.4.8.2. Argentina
10.4.8.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Screening Method
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.8.1. China
10.5.8.2. India
10.5.8.3. Japan
10.5.8.4. South Korea
10.5.8.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Screening Method
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
11.1. Competitive Overview and Key Market Players
11.1.1. Market Share Analysis and Positioning Matrix
11.1.2. Strategic Partnerships, Mergers & Acquisitions
11.1.3. Key Developments in Product Portfolios and Innovations
11.1.4. Company Benchmarking
12. COMPANY PROFILES
12.1. Modern Life, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio
12.1.2.1. Product Description
12.1.2.2. Product Key Performance Indicators (KPIs)
12.1.2.3. Historic and Forecasted Product Sales
12.1.2.4. Product Sales Volume
12.1.3. Financial Overview
12.1.3.1. Company Revenue
12.1.3.2. Geographical Revenue Shares
12.1.3.3. Revenue Forecasts
12.1.4. Key Developments
12.1.4.1. Mergers & Acquisitions
12.1.4.2. Key Product Development Activities
12.1.4.3. Regulatory Approvals, etc.
12.1.4.4. SWOT Analysis
12.2. FuturesThrive
12.3. Aiberry
12.4. Ezovion
12.5. AdvancedMD, Inc.
12.6. Networking Technology, Inc. dba RXNT
12.7. Amaha
12.8. Wellin5 Innovations Inc. (LIST NOT EXHAUSTIVE)
13. ASSUMPTIONS AND RESEARCH METHODOLOGY
13.1. Data Collection Methods
13.2. Data Triangulation
13.3. Forecasting Techniques
13.4. Data Verification and Validation
14. APPENDIX
14.1. About Us and Services
14.2. Contact Us
LIST OF TABLES
Table 1 Global Mental Health Screening Market Value, By Disorder Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Mental Health Screening Market Value, By Screening Method, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Mental Health Screening Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Mental Health Screening Market Value, By Age Group, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Mental Health Screening Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Mental Health Screening Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Mental Health Screening Market Value, By Disorder Type, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Mental Health Screening Market Value, By Disorder Type, 2022-2033 (US$ Billion)
Table 9 Global Mental Health Screening Market Value, By Screening Method, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Mental Health Screening Market Value, By Screening Method, 2022-2033 (US$ Billion)
Table 11 Global Mental Health Screening Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Mental Health Screening Market Value, By Component, 2022-2033 (US$ Billion)
Table 13 Global Mental Health Screening Market Value, By Age Group, 2025, 2029 & 2033 (US$ Billion)
Table 14 Global Mental Health Screening Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 15 Global Mental Health Screening Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 16 Global Mental Health Screening Market Value, By End-User, 2022-2033 (US$ Billion)
Table 17 Global Mental Health Screening Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 18 Global Mental Health Screening Market Value, By Region, 2022-2033 (US$ Billion)
Table 19 North America Mental Health Screening Market Value, By Disorder Type, 2022-2033 (US$ Billion)
Table 20 North America Mental Health Screening Market Value, By Screening Method, 2022-2033 (US$ Billion)
Table 21 North America Mental Health Screening Market Value, By Component, 2022-2033 (US$ Billion)
Table 22 North America Mental Health Screening Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 23 North America Mental Health Screening Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 North America Mental Health Screening Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Mental Health Screening Market Value, By Disorder Type, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Mental Health Screening Market Value, By Screening Method, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Mental Health Screening Market Value, By Component, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Mental Health Screening Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 29 Asia-Pacific Mental Health Screening Market Value, By End-User, 2022-2033 (US$ Billion)
Table 30 Asia-Pacific Mental Health Screening Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 Europe Mental Health Screening Market Value, By Disorder Type, 2022-2033 (US$ Billion)
Table 32 Europe Mental Health Screening Market Value, By Screening Method, 2022-2033 (US$ Billion)
Table 33 Europe Mental Health Screening Market Value, By Component, 2022-2033 (US$ Billion)
Table 34 Europe Mental Health Screening Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 35 Europe Mental Health Screening Market Value, By End-User, 2022-2033 (US$ Billion)
Table 36 Europe Mental Health Screening Market Value, By Country, 2022-2033 (US$ Billion)
Table 37 South America Mental Health Screening Market Value, By Disorder Type, 2022-2033 (US$ Billion)
Table 38 South America Mental Health Screening Market Value, By Screening Method, 2022-2033 (US$ Billion)
Table 39 South America Mental Health Screening Market Value, By Component, 2022-2033 (US$ Billion)
Table 40 South America Mental Health Screening Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 41 South America Mental Health Screening Market Value, By End-User, 2022-2033 (US$ Billion)
Table 42 South America Mental Health Screening Market Value, By Country, 2022-2033 (US$ Billion)
Table 43 Middle East and Africa Mental Health Screening Market Value, By Disorder Type, 2022-2033 (US$ Billion)
Table 44 Middle East and Africa Mental Health Screening Market Value, By Screening Method, 2022-2033 (US$ Billion)
Table 45 Middle East and Africa Mental Health Screening Market Value, By Component, 2022-2033 (US$ Billion)
Table 46 Middle East and Africa Mental Health Screening Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 47 Middle East and Africa Mental Health Screening Market Value, By End-User, 2022-2033 (US$ Billion)
Table 48 Middle East and Africa Mental Health Screening Market Value, By Country, 2022-2033 (US$ Billion)
Table 49 Modern Life, Inc.: Overview
Table 50 Modern Life, Inc.: Product Portfolio
Table 51 Modern Life, Inc.: Key Developments
Table 52 FuturesThrive: Overview
Table 53 FuturesThrive: Product Portfolio
Table 54 FuturesThrive: Key Developments
Table 55 Aiberry: Overview
Table 56 Aiberry: Product Portfolio
Table 57 Aiberry: Key Developments
Table 58 Ezovion: Overview
Table 59 Ezovion: Product Portfolio
Table 60 Ezovion: Key Developments
Table 61 AdvancedMD, Inc.: Overview
Table 62 AdvancedMD, Inc.: Product Portfolio
Table 63 AdvancedMD, Inc.: Key Developments
Table 64 Networking Technology, Inc. dba RXNT: Overview
Table 65 Networking Technology, Inc. dba RXNT: Product Portfolio
Table 66 Networking Technology, Inc. dba RXNT: Key Developments
Table 67 Amaha: Overview
Table 68 Amaha: Product Portfolio
Table 69 Amaha: Key Developments
Table 70 Wellin5 Innovations Inc.: Overview
Table 71 Wellin5 Innovations Inc.: Product Portfolio
Table 72 Wellin5 Innovations Inc.: Key Developments
Table 1 Global Mental Health Screening Market Value, By Disorder Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Mental Health Screening Market Value, By Screening Method, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Mental Health Screening Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Mental Health Screening Market Value, By Age Group, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Mental Health Screening Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Mental Health Screening Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Mental Health Screening Market Value, By Disorder Type, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Mental Health Screening Market Value, By Disorder Type, 2022-2033 (US$ Billion)
Table 9 Global Mental Health Screening Market Value, By Screening Method, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Mental Health Screening Market Value, By Screening Method, 2022-2033 (US$ Billion)
Table 11 Global Mental Health Screening Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Mental Health Screening Market Value, By Component, 2022-2033 (US$ Billion)
Table 13 Global Mental Health Screening Market Value, By Age Group, 2025, 2029 & 2033 (US$ Billion)
Table 14 Global Mental Health Screening Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 15 Global Mental Health Screening Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 16 Global Mental Health Screening Market Value, By End-User, 2022-2033 (US$ Billion)
Table 17 Global Mental Health Screening Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 18 Global Mental Health Screening Market Value, By Region, 2022-2033 (US$ Billion)
Table 19 North America Mental Health Screening Market Value, By Disorder Type, 2022-2033 (US$ Billion)
Table 20 North America Mental Health Screening Market Value, By Screening Method, 2022-2033 (US$ Billion)
Table 21 North America Mental Health Screening Market Value, By Component, 2022-2033 (US$ Billion)
Table 22 North America Mental Health Screening Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 23 North America Mental Health Screening Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 North America Mental Health Screening Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Mental Health Screening Market Value, By Disorder Type, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Mental Health Screening Market Value, By Screening Method, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Mental Health Screening Market Value, By Component, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Mental Health Screening Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 29 Asia-Pacific Mental Health Screening Market Value, By End-User, 2022-2033 (US$ Billion)
Table 30 Asia-Pacific Mental Health Screening Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 Europe Mental Health Screening Market Value, By Disorder Type, 2022-2033 (US$ Billion)
Table 32 Europe Mental Health Screening Market Value, By Screening Method, 2022-2033 (US$ Billion)
Table 33 Europe Mental Health Screening Market Value, By Component, 2022-2033 (US$ Billion)
Table 34 Europe Mental Health Screening Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 35 Europe Mental Health Screening Market Value, By End-User, 2022-2033 (US$ Billion)
Table 36 Europe Mental Health Screening Market Value, By Country, 2022-2033 (US$ Billion)
Table 37 South America Mental Health Screening Market Value, By Disorder Type, 2022-2033 (US$ Billion)
Table 38 South America Mental Health Screening Market Value, By Screening Method, 2022-2033 (US$ Billion)
Table 39 South America Mental Health Screening Market Value, By Component, 2022-2033 (US$ Billion)
Table 40 South America Mental Health Screening Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 41 South America Mental Health Screening Market Value, By End-User, 2022-2033 (US$ Billion)
Table 42 South America Mental Health Screening Market Value, By Country, 2022-2033 (US$ Billion)
Table 43 Middle East and Africa Mental Health Screening Market Value, By Disorder Type, 2022-2033 (US$ Billion)
Table 44 Middle East and Africa Mental Health Screening Market Value, By Screening Method, 2022-2033 (US$ Billion)
Table 45 Middle East and Africa Mental Health Screening Market Value, By Component, 2022-2033 (US$ Billion)
Table 46 Middle East and Africa Mental Health Screening Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 47 Middle East and Africa Mental Health Screening Market Value, By End-User, 2022-2033 (US$ Billion)
Table 48 Middle East and Africa Mental Health Screening Market Value, By Country, 2022-2033 (US$ Billion)
Table 49 Modern Life, Inc.: Overview
Table 50 Modern Life, Inc.: Product Portfolio
Table 51 Modern Life, Inc.: Key Developments
Table 52 FuturesThrive: Overview
Table 53 FuturesThrive: Product Portfolio
Table 54 FuturesThrive: Key Developments
Table 55 Aiberry: Overview
Table 56 Aiberry: Product Portfolio
Table 57 Aiberry: Key Developments
Table 58 Ezovion: Overview
Table 59 Ezovion: Product Portfolio
Table 60 Ezovion: Key Developments
Table 61 AdvancedMD, Inc.: Overview
Table 62 AdvancedMD, Inc.: Product Portfolio
Table 63 AdvancedMD, Inc.: Key Developments
Table 64 Networking Technology, Inc. dba RXNT: Overview
Table 65 Networking Technology, Inc. dba RXNT: Product Portfolio
Table 66 Networking Technology, Inc. dba RXNT: Key Developments
Table 67 Amaha: Overview
Table 68 Amaha: Product Portfolio
Table 69 Amaha: Key Developments
Table 70 Wellin5 Innovations Inc.: Overview
Table 71 Wellin5 Innovations Inc.: Product Portfolio
Table 72 Wellin5 Innovations Inc.: Key Developments
LIST OF FIGURES
Figure 1 Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Mental Health Screening Market Share, By Disorder Type, 2024 & 2033 (%)
Figure 3 Global Mental Health Screening Market Share, By Screening Method, 2024 & 2033 (%)
Figure 4 Global Mental Health Screening Market Share, By Component, 2024 & 2033 (%)
Figure 5 Global Mental Health Screening Market Share, By Age Group, 2024 & 2033 (%)
Figure 6 Global Mental Health Screening Market Share, By End-User, 2024 & 2033 (%)
Figure 7 Global Mental Health Screening Market Share, By Region, 2024 & 2033 (%)
Figure 8 Global Mental Health Screening Market Y-o-Y Growth, By Disorder Type, 2023-2033 (%)
Figure 9 Cognitive Disorders Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 10 Behavioral Disorders Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 11 Physiological Disorders Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 12 Psychotic Disorders Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 13 Global Mental Health Screening Market Y-o-Y Growth, By Screening Method, 2023-2033 (%)
Figure 14 Self-Reported Questionnaires Screening Method in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 15 Clinical Interviews Screening Method in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 16 Observation-Based Assessments Screening Method in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 17 Biomarker Testing Screening Method in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 18 Others Screening Method in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 19 Global Mental Health Screening Market Y-o-Y Growth, By Component, 2023-2033 (%)
Figure 20 Hardware Component in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 21 Software Component in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 22 Services Component in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 23 Global Mental Health Screening Market Y-o-Y Growth, By Age Group, 2023-2033 (%)
Figure 24 Children Age Group in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 25 Adults (Age 19-64) Age Group in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 26 Seniors (Age 65 and above) Age Group in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 27 Global Mental Health Screening Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 28 Hospitals and Clinics End-User in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 29 Educational Institutions End-User in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 30 Workplaces End-User in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 31 Homecare Settings End-User in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 32 Global Mental Health Screening Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 33 North America Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 34 North America Mental Health Screening Market Share, By Disorder Type, 2024 & 2033 (%)
Figure 35 North America Mental Health Screening Market Share, By Screening Method, 2024 & 2033 (%)
Figure 36 North America Mental Health Screening Market Share, By Component, 2024 & 2033 (%)
Figure 37 North America Mental Health Screening Market Share, By Age Group, 2024 & 2033 (%)
Figure 38 North America Mental Health Screening Market Share, By End-User, 2024 & 2033 (%)
Figure 39 North America Mental Health Screening Market Share, By Country, 2024 & 2033 (%)
Figure 40 Asia-Pacific Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 41 Asia-Pacific Mental Health Screening Market Share, By Disorder Type, 2024 & 2033 (%)
Figure 42 Asia-Pacific Mental Health Screening Market Share, By Screening Method, 2024 & 2033 (%)
Figure 43 Asia-Pacific Mental Health Screening Market Share, By Component, 2024 & 2033 (%)
Figure 44 Asia-Pacific Mental Health Screening Market Share, By Age Group, 2024 & 2033 (%)
Figure 45 Asia-Pacific Mental Health Screening Market Share, By End-User, 2024 & 2033 (%)
Figure 46 Asia-Pacific Mental Health Screening Market Share, By Country, 2024 & 2033 (%)
Figure 47 Europe Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 48 Europe Mental Health Screening Market Share, By Disorder Type, 2024 & 2033 (%)
Figure 49 Europe Mental Health Screening Market Share, By Screening Method, 2024 & 2033 (%)
Figure 50 Europe Mental Health Screening Market Share, By Component, 2024 & 2033 (%)
Figure 51 Europe Mental Health Screening Market Share, By Age Group, 2024 & 2033 (%)
Figure 52 Europe Mental Health Screening Market Share, By End-User, 2024 & 2033 (%)
Figure 53 Europe Mental Health Screening Market Share, By Country, 2024 & 2033 (%)
Figure 54 South America Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 55 South America Mental Health Screening Market Share, By Disorder Type, 2024 & 2033 (%)
Figure 56 South America Mental Health Screening Market Share, By Screening Method, 2024 & 2033 (%)
Figure 57 South America Mental Health Screening Market Share, By Component, 2024 & 2033 (%)
Figure 58 South America Mental Health Screening Market Share, By Age Group, 2024 & 2033 (%)
Figure 59 South America Mental Health Screening Market Share, By End-User, 2024 & 2033 (%)
Figure 60 South America Mental Health Screening Market Share, By Country, 2024 & 2033 (%)
Figure 61 Middle East and Africa Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 62 Middle East and Africa Mental Health Screening Market Share, By Disorder Type, 2024 & 2033 (%)
Figure 63 Middle East and Africa Mental Health Screening Market Share, By Screening Method, 2024 & 2033 (%)
Figure 64 Middle East and Africa Mental Health Screening Market Share, By Component, 2024 & 2033 (%)
Figure 65 Middle East and Africa Mental Health Screening Market Share, By Age Group, 2024 & 2033 (%)
Figure 66 Middle East and Africa Mental Health Screening Market Share, By End-User, 2024 & 2033 (%)
Figure 67 Modern Life, Inc.: Financials
Figure 68 FuturesThrive: Financials
Figure 69 Aiberry: Financials
Figure 70 Ezovion: Financials
Figure 71 AdvancedMD, Inc.: Financials
Figure 72 Networking Technology, Inc. dba RXNT: Financials
Figure 73 Amaha: Financials
Figure 74 Wellin5 Innovations Inc.: Financials
Figure 1 Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Mental Health Screening Market Share, By Disorder Type, 2024 & 2033 (%)
Figure 3 Global Mental Health Screening Market Share, By Screening Method, 2024 & 2033 (%)
Figure 4 Global Mental Health Screening Market Share, By Component, 2024 & 2033 (%)
Figure 5 Global Mental Health Screening Market Share, By Age Group, 2024 & 2033 (%)
Figure 6 Global Mental Health Screening Market Share, By End-User, 2024 & 2033 (%)
Figure 7 Global Mental Health Screening Market Share, By Region, 2024 & 2033 (%)
Figure 8 Global Mental Health Screening Market Y-o-Y Growth, By Disorder Type, 2023-2033 (%)
Figure 9 Cognitive Disorders Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 10 Behavioral Disorders Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 11 Physiological Disorders Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 12 Psychotic Disorders Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 13 Global Mental Health Screening Market Y-o-Y Growth, By Screening Method, 2023-2033 (%)
Figure 14 Self-Reported Questionnaires Screening Method in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 15 Clinical Interviews Screening Method in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 16 Observation-Based Assessments Screening Method in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 17 Biomarker Testing Screening Method in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 18 Others Screening Method in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 19 Global Mental Health Screening Market Y-o-Y Growth, By Component, 2023-2033 (%)
Figure 20 Hardware Component in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 21 Software Component in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 22 Services Component in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 23 Global Mental Health Screening Market Y-o-Y Growth, By Age Group, 2023-2033 (%)
Figure 24 Children Age Group in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 25 Adults (Age 19-64) Age Group in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 26 Seniors (Age 65 and above) Age Group in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 27 Global Mental Health Screening Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 28 Hospitals and Clinics End-User in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 29 Educational Institutions End-User in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 30 Workplaces End-User in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 31 Homecare Settings End-User in Global Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 32 Global Mental Health Screening Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 33 North America Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 34 North America Mental Health Screening Market Share, By Disorder Type, 2024 & 2033 (%)
Figure 35 North America Mental Health Screening Market Share, By Screening Method, 2024 & 2033 (%)
Figure 36 North America Mental Health Screening Market Share, By Component, 2024 & 2033 (%)
Figure 37 North America Mental Health Screening Market Share, By Age Group, 2024 & 2033 (%)
Figure 38 North America Mental Health Screening Market Share, By End-User, 2024 & 2033 (%)
Figure 39 North America Mental Health Screening Market Share, By Country, 2024 & 2033 (%)
Figure 40 Asia-Pacific Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 41 Asia-Pacific Mental Health Screening Market Share, By Disorder Type, 2024 & 2033 (%)
Figure 42 Asia-Pacific Mental Health Screening Market Share, By Screening Method, 2024 & 2033 (%)
Figure 43 Asia-Pacific Mental Health Screening Market Share, By Component, 2024 & 2033 (%)
Figure 44 Asia-Pacific Mental Health Screening Market Share, By Age Group, 2024 & 2033 (%)
Figure 45 Asia-Pacific Mental Health Screening Market Share, By End-User, 2024 & 2033 (%)
Figure 46 Asia-Pacific Mental Health Screening Market Share, By Country, 2024 & 2033 (%)
Figure 47 Europe Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 48 Europe Mental Health Screening Market Share, By Disorder Type, 2024 & 2033 (%)
Figure 49 Europe Mental Health Screening Market Share, By Screening Method, 2024 & 2033 (%)
Figure 50 Europe Mental Health Screening Market Share, By Component, 2024 & 2033 (%)
Figure 51 Europe Mental Health Screening Market Share, By Age Group, 2024 & 2033 (%)
Figure 52 Europe Mental Health Screening Market Share, By End-User, 2024 & 2033 (%)
Figure 53 Europe Mental Health Screening Market Share, By Country, 2024 & 2033 (%)
Figure 54 South America Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 55 South America Mental Health Screening Market Share, By Disorder Type, 2024 & 2033 (%)
Figure 56 South America Mental Health Screening Market Share, By Screening Method, 2024 & 2033 (%)
Figure 57 South America Mental Health Screening Market Share, By Component, 2024 & 2033 (%)
Figure 58 South America Mental Health Screening Market Share, By Age Group, 2024 & 2033 (%)
Figure 59 South America Mental Health Screening Market Share, By End-User, 2024 & 2033 (%)
Figure 60 South America Mental Health Screening Market Share, By Country, 2024 & 2033 (%)
Figure 61 Middle East and Africa Mental Health Screening Market Value, 2022-2033 (US$ Billion)
Figure 62 Middle East and Africa Mental Health Screening Market Share, By Disorder Type, 2024 & 2033 (%)
Figure 63 Middle East and Africa Mental Health Screening Market Share, By Screening Method, 2024 & 2033 (%)
Figure 64 Middle East and Africa Mental Health Screening Market Share, By Component, 2024 & 2033 (%)
Figure 65 Middle East and Africa Mental Health Screening Market Share, By Age Group, 2024 & 2033 (%)
Figure 66 Middle East and Africa Mental Health Screening Market Share, By End-User, 2024 & 2033 (%)
Figure 67 Modern Life, Inc.: Financials
Figure 68 FuturesThrive: Financials
Figure 69 Aiberry: Financials
Figure 70 Ezovion: Financials
Figure 71 AdvancedMD, Inc.: Financials
Figure 72 Networking Technology, Inc. dba RXNT: Financials
Figure 73 Amaha: Financials
Figure 74 Wellin5 Innovations Inc.: Financials
